NEU GRAND LIBRARY
Opening Hours: Monday-Saturday, 08:00-20:00 | E-mail: library@neu.edu.tr
 

You are not logged in Show Basket
  Home     Advanced Search     Back  
  Brief display     MARC Display     Reserve  
Propofol-related infusion syndrome in a geriatric patient following the use of propofol in low doses and short duration, during and after cardiac surgery (Ozcem, Barcin.)
Bibliographical information (record 264533)
Help
Propofol-related infusion syndrome in a geriatric patient following the use of propofol in low doses and short duration, during and after cardiac surgery
Author:
Ozcem, Barcin. Search Author in Amazon Books

Edition:
2014.
Classification:
HQ1061
Detailed notes
    - Propofol, is a potent short-acting intravenous sedative-hypnotic agent used for induction and maintainance of general anesthesia and to provide continuous sedation in the intensive care unit. Propofol-related infusion syndrome (PRIS) is a rare yet often fatal syndrome associated with the continuous infusion of propofol. It is characterized by severe metabolic acidosis, cardiac failure, bradycardia, myoglobinuria and renal failure. Hereby we present a case of PRIS which developed in a geriatric patient (74y), following coronary artery by-pass grafting and aortic valve replacement surgery in the early postoperative period. Propofol was used in low doses both intraoperatively and in the intensive care unit (ICU) postoperatively. The patient developed severe lactic acidosis, oliguria and bradycardia requiring cardiac pacing in the 6th hour postoperatively. Lactic acidosis and clinical condition improved promptly within a few hours, following the discontinuation of propofol infusion.
Related links
Items (1)
Barcode
Status
Library
Section
EOL-129
Item available
NEU Grand LibraryOnline (HQ1061 .P76 2014)
Online electronic

NEAR EAST UNIVERSITY GRAND LIBRARY +90 (392) 223 64 64 Ext:5536. Near East Boulevard, Nicosia, TRNC
This software is developed by NEU Library and it is based on Koha OSS
conforms to MARC21 library data transfer rules.